FitMi Plus Home Therapy for Stroke Patients

Sponsor
Flint Rehabilitation Devices, LLC (Industry)
Overall Status
Recruiting
CT.gov ID
NCT03935425
Collaborator
University of California, Irvine (Other), Rancho Research Institute, Inc. (Other)
50
2
2
18
25
1.4

Study Details

Study Description

Brief Summary

The investigators will investigate the efficacy of a newly developed functional exercise device (FitMi Plus) for people in the chronic stage after a stroke compared to the FitMi Basic (i.e. without functional exercises). FitMi Plus combines objects commonly used during activities of daily living with sensors that can track and record the patient's direction and degree of movement as they perform specific functional tasks described on a computer.

Condition or Disease Intervention/Treatment Phase
  • Device: FitMi Plus
  • Device: FitMi Basic
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
50 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Double (Participant, Outcomes Assessor)
Primary Purpose:
Treatment
Official Title:
FitMi Plus: Smart Functional Modules for Practicing Activities of Daily Living After Stroke
Actual Study Start Date :
Jul 1, 2021
Anticipated Primary Completion Date :
Oct 31, 2022
Anticipated Study Completion Date :
Dec 31, 2022

Arms and Interventions

Arm Intervention/Treatment
Experimental: FitMi Plus

Participants will perform targeted movement exercises by interacting with the FitMi Plus Functional modules at least 50% of the time they spend exercising. Participants will be asked to exercise at least 3 hours per week for 3 consecutive weeks.

Device: FitMi Plus
A set of common objects that couple with a wireless sensor platform to allow the performance of functional exercises to be measured by a motivating software platform.

Active Comparator: FitMi Basic

Participants will perform targeted movement exercises by interacting with the FitMi Basic pucks, as described and monitored on a computer. Participants will be asked to exercise at least 3 hours per week for 3 consecutive weeks.

Device: FitMi Basic
A wireless sensor platform that allows movement subcomponents and point-to-point exercises to be measured by a motivating software platform.

Outcome Measures

Primary Outcome Measures

  1. Change in Motor Activity Log [Baseline, Immediately Post-Treatment, One-Month Post-Treatment.]

    A self-reported measure of the quality of movement and amount of use of the impaired upper extremity across a set of activities of daily living.

Secondary Outcome Measures

  1. Change in Upper Extremity Fugl-Meyer [Baseline, Immediately Post-Treatment, One-Month Post-Treatment.]

    A standardized assessment of arm impairment based on scores of 0-2 on 33 different tasks.

  2. Action Research Arm Test [Baseline, Immediately Post-Treatment, One-Month Post-Treatment.]

    A 19 item measure divided into 4 sub-tests (grasp, grip, pinch, and gross arm movement). Performance on each item is rated on a 4-point ordinal scale ranging from: 3) Performs test normally 2) Completes test, but takes abnormally long or has great difficulty 1) Performs test partially 0) Can perform no part of test

  3. Modified Ashworth Spasticity Scale [Baseline, Immediately Post-Treatment, One-Month Post-Treatment]

    Tests resistance to passive movement about a joint with varying degrees of velocity. Scores range from 0-4, with 6 choices.

  4. Visual Analog Pain Scale [Baseline, Immediately Post-Treatment, One-Month Post-Treatment.]

    The Visual Analog Pain Scale is a unidimensional measure of pain intensity, which has been widely used in diverse adult populations. The scale ranges from 0) "no pain" to 10) "worst possible, unbearable pain"

  5. Wearable Activity Tracking [Baseline, One-Month Post-Treatment.]

    Participants wear a custom-designed wrist-mounted actigrapher (the MiGo, which uses wrist-worn accelerometers to monitor functional use of the upper extremity activity) for a 24 hour period to assess changes in functional activity levels.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 85 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Experienced 1 or more strokes >6 months prior to enrollment

  • Upper Extremity Fugl-Meyer Score >=15 and <=55 out of 66

  • Absence of moderate to severe upper extremity pain (<= 4 out of 10 on the visual-analog pain scale)

  • Ability to understand the instructions to operate FitMi products

Exclusion Criteria:
  • Lack of concurrent severe medical problems

  • Lack of visual deficits

  • Lack of severe neglect or apraxia

  • No concurrent enrollment in another therapy study

Contacts and Locations

Locations

Site City State Country Postal Code
1 Rancho Research Institute, Inc Downey California United States 90242
2 Human Neuroperformance Laboratory at University of California Irvine Irvine California United States 926170000

Sponsors and Collaborators

  • Flint Rehabilitation Devices, LLC
  • University of California, Irvine
  • Rancho Research Institute, Inc.

Investigators

  • Principal Investigator: David Reinkensmeyer, PhD, University of California, Irvine
  • Principal Investigator: Susan Shaw, MD, Rancho Research Institute, Inc.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Flint Rehabilitation Devices, LLC, Vice President, Flint Rehabilitation Devices, LLC
ClinicalTrials.gov Identifier:
NCT03935425
Other Study ID Numbers:
  • 1R44HD097803-01
First Posted:
May 2, 2019
Last Update Posted:
Dec 15, 2021
Last Verified:
Dec 1, 2021
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
Yes
Product Manufactured in and Exported from the U.S.:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Dec 15, 2021